Company Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:02 2025-04-23 pm EDT After market 05:32:16 pm
22.39 USD -0.62% Intraday chart for Pfizer, Inc. 22.46 +0.29%

Business description: Pfizer, Inc.

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows:

- primary care products (47.4%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.;

- specialty care products (26.2%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.;

- oncology products (24.5%);

- other (1.9%).

The United States accounts for 60.8% of net sales.

Number of employees: 81,000

Sales by Activity: Pfizer, Inc.

Fiscal Period: December20202021202220232024

Global Biopharmaceuticals Business (Biopharma)

41.91B 79.56B 98.99B 57.19B 62.4B

Pfizer Centreone (pc1)

- - - - 1.15B

Pfizer Ignite

- - - - 82M

Other business activities

- 1.73B 1.34B 1.31B -
See all business segments

Geographical breakdown of sales: Pfizer, Inc.

Fiscal Period: December20202021202220232024

United States

21.71B 29.75B 42.47B 27.09B 38.69B

Developed Markets

- - - - 16.06B

Emerging Markets

8.37B 20.7B 20.1B 12B 8.88B

Developed Europe

7.79B 18.34B 21.98B 11.65B -

International

4.04B 12.51B 15.78B 7.76B -
See all geographic segments

Executive Committee: Pfizer, Inc.

Manager TitleAgeSince
Chief Executive Officer 63 2018-12-31
Director of Finance/CFO 60 2022-05-01
Chief Tech/Sci/R&D Officer - 2024-12-31
Chief Tech/Sci/R&D Officer 61 2022-08-31
Compliance Officer 64 2013-11-30
See PFIZER, INC. governance

Composition of the Board of Directors: Pfizer, Inc.

Director TitleAgeSince
Director/Board Member 67 2007-08-31
Director/Board Member 72 2011-12-11
Director/Board Member 61 2013-09-26
Chairman 63 2019-12-31
Director/Board Member 65 2014-06-25
Director/Board Member 67 2015-06-24
Director/Board Member 65 2017-02-22
Director/Board Member 72 2018-03-04
Director/Board Member 52 2019-06-26
Director/Board Member 60 2020-02-26
Composition of the Board of Directors

Shareholders: Pfizer, Inc.

NameEquities%Valuation
Vanguard Fiduciary Trust Co.
9.15 %
518,535,151 9.15 % 13 140 M $
BlackRock Advisors LLC
5.84 %
330,938,055 5.84 % 8 386 M $
5.126 %
290,484,350 5.126 % 7 361 M $
Wellington Trust Co., NA
2.47 %
139,990,889 2.47 % 3 547 M $
Geode Capital Management LLC
2.128 %
120,589,782 2.128 % 3 056 M $
NameEquities%Valuation
Caixa DTVM SA
0.001419 %
321,692 0.001419 % 2 M $
Itaú Unibanco SA
0.001279 %
289,900 0.001279 % 2 M $
BRAM - Bradesco Asset Management SA DTVM
0.000204 %
46,246 0.000204 % 292 446 $
Credit Suisse Hedging-Griffo Corretora de Valores SA
0.000088 %
20,000 0.000088 % 126 474 $
BTG Pactual WM Gestão de Recursos Ltda.
0.000011 %
2,438 0.000011 % 15 417 $
List of PFIZER, INC. shareholders

Holdings: Pfizer, Inc.

NameEquities%Valuation
29,243,042 63.92% 1,369,887,086 $
3,658,361 1.54% 333,130,353 $
115,928,803 9.03% 49,319,591 $
22,032,040 10.14% 32,166,778 $
9,549,761 5.88% 31,854,756 $
5,376,344 7.57% 30,000,000 $
3,457,815 5.03% 24,273,861 $
562,626 0.75% 22,775,100 $
1,272,214 4.96% 19,350,375 $
1,875,000 1.23% 15,150,000 $

Company details: Pfizer, Inc.

Pfizer Inc.

66 Hudson Boulevard East

10001-2192, New York

+212 733 2323

http://www.pfizer.com
address Pfizer, Inc.(PFE)

Group companies: Pfizer, Inc.

NameCategory and Sector
Pharmaceuticals: Major
Pharmaceuticals: Major
Pharmaceuticals: Major
Medical Distributors
Pfizer Overseas LLC
See all subsidiaries

Other Pharmaceuticals

Change 5d. change 1-year change 3-years change Capi.($)
-0.62%+1.22%-14.74%-54.41% 128B
+0.23%+9.95%+13.41%+186.39% 743B
-1.50%+0.66%+4.20%-15.26% 380B
+1.88%-1.14%+5.46%+11.69% 307B
+4.85%-6.18%-53.28%+6.08% 266B
+1.30%+2.54%+14.30%-29.54% 251B
+0.24%+2.43%+4.05%+5.40% 212B
+2.19%+0.41%-7.89%-1.35% 210B
-0.29%-0.54%-37.97%-8.69% 199B
-0.18%-5.45%+2.20%+8.78% 150B
Average +0.97%-0.38%-7.03%+10.91% 284.65B
Weighted average by Cap. +0.91%+1.50%-2.55%+43.56%
See all sector performances
Trading Rating
Investor Rating
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
22.53USD
Average target price
29.43USD
Spread / Average Target
+30.62%
Consensus

Quarterly revenue - Rate of surprise